Current Practices on the Use of Sildenafil Citrate for Pulmonary Arterial Hypertension in Brazilian Hospitals

BMC Research Notes - United Kingdom
doi 10.1186/1756-0500-2-30
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Impact of First-Line Sildenafil Monotreatment for Pulmonary Arterial Hypertension

Circulation Journal
MedicineCardiovascular MedicineCardiology
2012English

Right Ventricular Reverse Remodelling After Sildenafil in Pulmonary Arterial Hypertension

Heart
Cardiovascular MedicineCardiology
2006English

Current Management of Pulmonary Arterial Hypertension

Prescriber
Pharmacology
2017English

Prognostication in Pulmonary Arterial Hypertension and Use of Current Risk Prediction Models

Advances in Pulmonary Hypertension
2015English

Formulation Development and Statistical Optimization of a Bilayer Tablet of Bosentan Monohydrate and Sildenafil Citrate in Management of Pulmonary Arterial Hypertension

International Journal of Applied Pharmaceutics
Pharmaceutical Science
2019English

Combining Bosentan and Sildenafil in Pulmonary Arterial Hypertension Patients Failing Monotherapy: Real-World Insights

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2015English

Pulmonary Arterial Hypertension

Current Problems in Cardiology
MedicineCardiovascular MedicineCardiology
2011English

Early Observations on the Use of Riociguat in a Large, Metropolitan Pulmonary Arterial Hypertension/Chronic Thromboembolic Pulmonary Hypertension Treatment Center

Cardiology and Therapy
2015English

Screening for Pulmonary Arterial Hypertension

Advances in Pulmonary Hypertension
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy